Name Michael Sela | ||
 | ||
Awards Wolf Prize in Medicine, Gairdner Foundation International Award | ||
Sara michael sela tribute
Michael Sela (Hebrew: מיכאל סלע) (born 2 March 1924) is an Israeli immunologist of Polish Jewish origin. He is W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science in Rehovot.
Contents
- Sara michael sela tribute
- Chemical Sciences D2S1 335 Drug Discovery Michael Sela
- Birth and academic career
- Research
- Awards and honours
- References
Chemical Sciences | D2S1 3/35 Drug Discovery - Michael Sela
Birth and academic career
Michael Sela was born as Mieczyslaw Solomonowicz in Tomaszów Mazowiecki, Poland, in 1924. Today, he is Professor in the Weizmann Institute's Immunology Department.
Research
Sela is known for his research in immunology, particularly for research on synthetic antigens, molecules that trigger the immune system to attack. These work of Sela have led to the discovery of the genetic control of the immune response, as well as to the design of vaccines based on synthetic molecules.
He was among the first who introduced the use of linear and branched synthetic polypeptides as antigens, and this brought about a better understanding of immunological phenomena.
For several decades, Sela have been interested in the possibility of fighting the autoimmune disease, experimental allergic encephalomyelitis (EAE) with synthetic analogs of the molecules in the myelin sheath of the brain which are capable of provoking the disease.
He is probably best known as the co-developer (with Ruth Arnon and Dvora Teitelbaum) of the multiple sclerosis drug copaxone.
Awards and honours
Sela has received several awards. Following are the major awards received by Sela.